Seattle, WA, USA--(Jobwerx News)--Valleylab acquires leading developer of microwave ablation medical technology Vivant Medical.

Tyco International Ltd. has announced that Valleylab, a division in Tyco's Healthcare segment, acquired Vivant Medical Inc., a leading developer of microwave ablation medical technology. The transaction is valued at approximately $66 million cash at close, with up to approximately $35 million additional to be paid in the future based on achieving certain milestones.

Vivant, an emerging technology company located in Mountain View, Calif., is developing the anticipated first-to-market microwave ablation medical technology. Ablation is a minimally invasive procedure used in a variety of medical treatments for various forms of cancer. Vivant's VivaWave™ Microwave Ablation System, indicated for soft tissue treatment, was developed to achieve more predictable procedure times, with greater accuracy and increased patient safety. The technology has been in successful clinical applications since late 2004 and the company expects to commercially release the product soon.

As a major business segment of Tyco International Ltd., Tyco Healthcare manufactures, distributes and services an extensive product line including disposable medical supplies, monitoring equipment, innovative wound closure products, advanced surgical devices, medical instruments and bulk analgesic pharmaceuticals. With industry-leading brand names such as Autosuture, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, Syneture and Valleylab.

"Vivant is an excellent strategic fit with our Healthcare focus of introducing the latest medical technologies to the market, improving patient results and healthcare efficiency," said Ed Breen, Tyco's Chairman and Chief Executive Officer. "In addition, this transaction is reflective of our near- term acquisition strategy of purchasing proven technology where we can leverage our global distribution capability."

"This acquisition addresses a tremendous unmet clinical need in the global marketplace," said Scott Drake, President of Valleylab. "The combination of Valleylab and Vivant offers interventional radiologists, surgeons and cancer patients the most comprehensive portfolio of technology and therapies to improve clinical outcomes."